Pain Management in Elderly Patients with Chronic Kidney Disease

Introduction to Pain Management

Fentanyl and buprenorphine are the safest opioid options for pain control in elderly patients with advanced chronic kidney disease, particularly those with eGFR <30 ml/min, according to the American College of Oncology 1
The American College of Oncology recommends using standardized pain assessment tools, such as Visual Analogue Scale (VAS), Verbal Rating Scale (VRS), and Numerical Rating Scale (NRS), for elderly patients 1

The American College of Oncology recommends acetaminophen (paracetamol) as a first-line treatment, which is safe in CKD patients, with a dosing of 650 mg every 6 hours (maximum 3g/day) 1
The National Comprehensive Cancer Network recommends avoiding NSAIDs due to high risk of renal, GI, and cardiac toxicities in elderly CKD patients, and instead using acetaminophen + low-dose strong opioid as a first-line treatment 2
The Kidney International society recommends using fentanyl or buprenorphine as a first-line treatment, with a transdermal route preferred for chronic pain, and starting at the lowest possible dose and titrating slowly 1

The American College of Oncology recommends starting with a low dose and titrating slowly, using regular scheduling rather than "as needed", and providing rescue doses for breakthrough pain, with an oral route preferred when possible 1
The American College of Oncology recommends using laxatives for prophylaxis of constipation and metoclopramide or antidopaminergic drugs for nausea/vomiting as mandatory adjunctive medications 1

The Kidney International society recommends monitoring for adverse effects, including confusion, excessive sedation, constipation, respiratory depression, and falls risk 3
The American College of Oncology recommends scheduling regular follow-up to assess pain control efficacy, medication side effects, need for dose adjustments, and changes in kidney function 1

The Kidney International society recommends avoiding NSAIDs for acute gout attacks and instead using low-dose colchicine (with dose adjustment for CKD) or intra-articular or oral glucocorticoids as preferred options 3
The American College of Oncology recommends providing clear instructions about medication schedule, potential side effects, when to contact healthcare provider, and signs of opioid toxicity 1